National Expert Group on Vaccine Administration for COVID-19

Last updated
National Expert Group on Vaccine Administration for COVID-19
AbbreviationNEGVAC
Legal statusActive
Location
  • India
Region served
India
LeaderV. K. Paul

National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) is an expert committee constituted by the Ministry of Health and Family Welfare (MoHFW), India to provide advice and guidance on all aspects of COVID-19 vaccination. The committee is also responsible for prioritisation of population groups in the country, deciding procurement and inventory management procedure, selection and delivery of vaccines etc. [1]

Committee

NEGVAC was constituted in mid-2020 and first met on 12 August 2020. [2] [3] [4] is chaired by member (Health), NITI Aayog, and co-chaired by the secretary of MoHFW. The committee has representative secretaries from: [1]

Members include Samiran Panda, head of the Epidemiology and Communicable Diseases division in ICMR. [5]

Related Research Articles

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.

The National Tuberculosis Elimination Program (NTEP) is the Public Health initiative of the Government of India that organizes its anti-Tuberculosis efforts. It functions as a flagship component of the National Health Mission (NHM) and provides technical and managerial leadership to anti-tuberculosis activities in the country. As per the National Strategic Plan 2017–25, the program has a vision of achieving a "TB free India",with a strategies under the broad themes of "Prevent, Detect,Treat and Build pillars for universal coverage and social protection". The program provides, various free of cost, quality tuberculosis diagnosis and treatment services across the country through the government health system.

The Department of Biotechnology (DBT) is an Indian government department, under the Ministry of Science and Technology responsible for administrating development and commercialisation in the field of modern biology and biotechnology in India. It was set up in 1986.

<span class="mw-page-title-main">Ram Sewak Sharma</span>

Ram Sewak Sharma is an Indian bureaucrat and former civil servant. From February 2021, he is serving as the Chief Executive Officer of the National Health Authority, an Indian governmental organisation tasked with managing public health insurance. Previously, he has headed the Telecom Regulatory Authority of India, and the Unique Identification Authority of India.

<span class="mw-page-title-main">Mission Indradhanush</span>

Mission Indradhanush is a health mission of the Government of India. It was launched by Union Health Minister J. P. Nadda on 25 December 2014. The scheme this seeks to drive towards 90% full immunisation coverage of India and sustain the same by year 2022. Vaccination is being provided against eight vaccine-preventable diseases nationally, i.e. Diphtheria, Whooping Cough, Tetanus, Polio, Measles, severe form of Childhood Tuberculosis and Hepatitis B and meningitis & pneumonia caused by Haemophilus influenza type B; and against Rotavirus Diarrhea and Japanese Encephalitis in selected states and districts respectively.

The Viral Research and Diagnostic Laboratories (VRDL) scheme was introduced by the Government of India under Department of Health Research - Indian Council of Medical Research as outbreaks of viral agents is very common in India. The Central government announced the establishment of 166 research and diagnostics laboratories in 2016. By 2019, 103 new VRDLs were established across India, taking the total count to 105.

<span class="mw-page-title-main">Soumya Swaminathan</span> Indian and WHO Deputy Director general

Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.

<span class="mw-page-title-main">Robert Kadlec</span>

Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services from August 2017 until January 2021. He is responsible for the creation of the COVID-19 vaccine development program Operation Warp Speed.

<span class="mw-page-title-main">Vinod Kumar Paul</span> Indian pediatrician

Vinod Kumar Paul is an Indian pediatrician and physician scientist currently serving as Member, NITI Aayog. He earlier served as Professor of Neonatology at the Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi from 1985 to 2020. He is associated with India's health policy as well as child and maternal health programs.

Preeti Sudan is a retired Indian bureaucrat who served as Health Secretary of India from October 2017 to July 2020. She has been the key strategist in times of the COVID-19 pandemic.

<span class="mw-page-title-main">COVID-19 pandemic in India</span> Ongoing COVID-19 viral pandemic in India

The COVID-19 pandemic in India is a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. As of 22 April 2023, according to Indian government figures, India has the second-highest number of confirmed cases in the world with 44,834,859 reported cases of COVID-19 infection and the third-highest number of COVID-19 deaths at 531,152 deaths. In October 2021, the World Health Organization estimated 4.7 million excess deaths, both directly and indirectly related to COVID-19 to have taken place in India.

<span class="mw-page-title-main">COVID-19 pandemic in Odisha</span> Ongoing COVID-19 viral pandemic in Odisha, India

The first case of the COVID-19 pandemic was confirmed in the Indian state of Odisha on 16 March 2020. The state has confirmed 10,00,084 cases, including 9,497 active cases, 9,83,245 recoveries, and 7,289 deaths as of 21 August 2021.

The first case of COVID-19 on the Union Territory of Lakshadweep was recorded on 18 January 2021. Lakshadweep Islands, until then, was India's only COVID-free territory (state/UT), and life was fairly normal for the residents of the UT. As of 13 September 2021, there were 10,297 confirmed cases and 51 deaths.

The COVID-19 pandemic reached the state of Nagaland on 22 May 2020, with its first case confirmed on 25 May 2020. Officially, Nagaland is the last of the northeastern states after Sikkim to report COVID-19 positive cases.

Nicola Mary Turner is a New Zealand public health advocate who is a Professor at the University of Auckland and Medical Director of the Immunisation Advisory Centre, an organisation that advises the New Zealand medical profession and the New Zealand Government. She has contributed to advisory committees for the New Zealand Ministry of Health, is a spokesperson for the Child Poverty Action Group and works in general practice. Much of her research and outreach has focused on improving immunisation coverage and closing equity gaps for the national schedule vaccine delivery in New Zealand and she has commented publicly on these issues during COVID-19 in New Zealand.

<span class="mw-page-title-main">Vaccine Taskforce</span> Non-departmental body coordinating efforts to introduce a COVID-19 vaccine

The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in April 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution. The taskforce coordinated the research efforts of government with industry, academics and funding agencies in order to expedite vaccine development and deployment.

The Australian Technical Advisory Group on Immunisation (ATAGI) is a technical advisory group of the Australian Government. As part of the Department of Health, ATAGI provides advice to the Minister of Health on the immunisation program of Australia and related matters, including the strength of evidence pertaining to existing, new, and emerging vaccines.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

<span class="mw-page-title-main">CoWIN</span> Indian Government COVID-19 vaccination portal

CoWIN is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry of Health and Family Welfare. It displays booking slots of COVID-19 vaccine available in the nearby areas and can be booked on the website. The site also provides vaccination certificates to the beneficiaries, which act as Vaccine Passports during the COVID-19 pandemic for the beneficiaries and can be stored in Digilocker. Users can access the platform via desktop, tablet, and mobile phones.

References

  1. 1 2 "High Level Committee for Distribution and Administration of COVID-19 Vaccines". pib.gov.in. Retrieved 19 May 2021.
  2. Das, Sohini (2020-08-17). "National Expert Group meets Covid-19 vaccine makers to discuss road ahead". Business Standard India. Retrieved 19 May 2021.
  3. 1 2 "National Expert Group on Vaccine Administration for COVID-19 deliberates on strategy to ensure COVID-19 vaccines' availability and its delivery mechanism". pib.gov.in. Retrieved 19 May 2021.
  4. "National Expert Group On Vaccine Administration Working On Management Of COVID-19 Vaccine Roll-Out: Government | News". NDTV-Dettol Banega Swasth Swachh India. 2020-12-09. Retrieved 19 May 2021.
  5. Sharma, Neetu Chandra (2021-03-08). "'Govt to tailor jab strategy as per emerging evidence'". mint. Retrieved 2021-06-03.